3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Skin Neoplasms
1
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Gliosarcoma
1
Glioblastoma
1
Carcinoma, Basal Cell
1
Interventions
Interferon beta-1b
2
Fingolimod Hydrochloride
2
teriflunomide
1
nabiximols
1
Platelet Transfusion
1
OM 89
1
Natalizumab
1
Mn-PyC3A
1
Magnetic Resonance Imaging
1
Interferon beta-1a
1
Fish Oils
1
Dimethyl Fumarate
1
Blood Specimen Collection
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Multiple Sclerosis
×
Dimethyl Fumarate
×
Clear all
NCT06705608
2024-11-26
MS; FTY720
University of British Columbia
Completed
4,000 enrolled